Created in May, 2015, by Centers for Disease Control and Prevention (CDC), Epidemiologist, Caitlin M. Worrell, M.P.H., this image depicts Mr. Daniel, a laboratory technician and transmission assessment surveys (TAS) team member, as he was comforting a young Haitian girl who was selected to take part in the TAS survey in the Dondon Commune in Northern Haiti. By testing the blood of school children for lymphatic filariasis (LF), the national program will be able to determine if mass drug administration campaigns have been successful in reducing the prevalence of LF in Haiti. The results will hopefully show that this child’s generation will be the first to be free of lymphatic filariasis. This was one of the entries in the 2015 CDC Connects, Public Health in Action Photo Contest.
Lymphatic filariasis (LF), more commonly known as elephantiasis, is a disfiguring parasitic disease. Globally, approximately 1.34 billion people are at risk for contracting LF and developing the disfiguring physical manifestations associated with this disease. Through mass drug administration the global community has made great progress towards eliminating LF as a public health problem. Further, the elimination of LF in the Americas is a CDC winnable battle. In support of this, CDC has partnered with the Haiti Ministry of Public Health and Population (Ministere de la Sante Publique et de la Population) to support mass drug administration and provide technical assistance for impact evaluations, known as transmission assessment surveys (TAS).
For more on what the CDC is accomplishing in Haiti, see the link below.